Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Hendriks, L.E.; Kerr, K.M.; Menis, J.; Mok, T.S.; Nestle, U.; Passaro, A.; Peters, S.; Planchard, D.; Smit, E.F.; Solomon, B.J.; Veronesi, G.; Reck, M.

doi:10.1016/j.annonc.2022.12.013

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Détails

Demande d'une copie

ID Serval

serval:BIB_0E714965871B

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Périodique

Annals of oncology

Auteur⸱e⸱s

Hendriks L.E., Kerr K.M., Menis J., Mok T.S., Nestle U., Passaro A., Peters S., Planchard D., Smit E.F., Solomon B.J., Veronesi G., Reck M.

Collaborateur⸱rice⸱s

ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

ISSN

1569-8041 (Electronic)

ISSN-L

0923-7534

Statut éditorial

Publié

Date de publication

04/2023

Peer-reviewed

Oui

Volume

34

Numéro

4

Pages

358-376

Langue

anglais

Notes

Publication types: Practice Guideline
Publication Status: ppublish

Mots-clé

Humans, Carcinoma, Non-Small-Cell Lung/diagnosis, Carcinoma, Non-Small-Cell Lung/genetics, Carcinoma, Non-Small-Cell Lung/therapy, Lung Neoplasms/diagnosis, Lung Neoplasms/genetics, Lung Neoplasms/therapy, Follow-Up Studies, ESCAT, ESMO Clinical Practice Guideline (CPG), ESMO-MCBS, immunotherapy, non-oncogene-addicted metastatic non-small-cell lung cancer (mNSCLC), treatment, targeted therapy

OAI-PMH

oai:serval.unil.ch:BIB_0E714965871B

DOI

10.1016/j.annonc.2022.12.013

Pubmed

36669645

Web of science

000982505500001

Open Access

Oui

Création de la notice

31/01/2023 16:35